Big Tech’s guide to talking about AI ethics
By Karen Hao,
MIT Technology Review
| 04. 13. 2021
50-ish words you can use to show that you care without incriminating yourself.
AI researchers often say good machine learning is really more art than science. The same could be said for effective public relations. Selecting the right words to strike a positive tone or reframe the conversation about AI is a delicate task: done well, it can strengthen one’s brand image, but done poorly, it can trigger an even greater backlash.
The tech giants would know. Over the last few years, they’ve had to learn this art quickly as they’ve faced increasing public distrust of their actions and intensifying criticism about their AI research and technologies.
Now they’ve developed a new vocabulary to use when they want to assure the public that they care deeply about developing AI responsibly—but want to make sure they don’t invite too much scrutiny. Here’s an insider’s guide to decoding their language and challenging the assumptions and values baked in.
accountability (n) - The act of holding someone else responsible for the consequences when your AI system fails.
accuracy (n) - Technical correctness. The most important measure of success in evaluating an AI model’s performance. See validation...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...